410 completed, 131 terminated, 69 active not recruiting, 69 recruiting. 353 Phase 2, 195 Phase 1, 139 Phase 4, 133 Phase 3, 58 Not applicable.
Follow Calcium Dobesilate: new trials by email Literature Review of Calcium Dobesilate trials Research Report on Calcium Dobesilate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse Biospecimen Collection, Bone Marrow Biopsy, Carfilzomib - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 80 | 2027-05-22 | 2026-10-23 |
| Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 74 | 2027-04-20 | 2026-10-07 |
| Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 162 | 2027-04-12 | 2026-10-16 |
| FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 24 | 2027-02-17 | 2026-08-27 |
| Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 / Phase 3 | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 432 | 2027-01-06 | 2026-10-01 |
| Low Dose Dexamethasone for the Prevention of Cytokine Release Syndrome Associated With Tebentafusp Dexamethasone - Uveal Melanoma, Metastatic | Phase 2 | Not yet recruiting | University of California, San Diego | 34 | 2026-11-01 | 2026-09-03 |
| Impact of Intravenous Dexamethasone on the Duration of Motor and Sensory Block Following Spinal Anesthesia With Chloroprocaine Intravenous Dexamethasone, Normal Saline - Spinal Anesthesia, Prolonged Sensory Block | Not applicable | Not yet recruiting | Centre hospitalier de l'Université de Montréal (CHUM) | 60 | 2026-11-01 | 2026-10-08 |
| Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma Biospecimen Collection, Cisplatin, Computed Tomography - Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma | Phase 1 | Not yet recruiting | National Cancer Institute (NCI) | 16 | 2026-10-30 | 2026-09-03 |
| Low-Volume Pericapsular Nerve Group (PENG) Block With Dexamethasone vs Standard-Volume PENG Block After Total Hip Arthroplasty Pericapsular nerve group (PENG) block, Bupivacaine, Dexamethasone - Pain, Postoperative, Muscle Weakness | Phase 4 | Recruiting | Ain Shams University | 60 | 2026-10-15 | 2026-10-16 |
| Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | SWOG Cancer Research Network | 90 | 2026-10-14 | 2026-10-13 |
| Carbon Monoxide Hyperbaric Oxygen With Steroid Therapy saline placebo, Dexamethasone - Carbon Monoxide Poisoning, Carbon Monoxide Intoxication | Phase 1 / Phase 2 | Not yet recruiting | University of Nebraska | 20 | 2026-10-01 | 2026-08-14 |
| Dose Dependent Steroid Injections Triamcinolone 10 Mg/mL Injectable Suspension, Triamcinolone 40 Mg/mL Injectable Suspension, Triamcinolone 80 Mg/mL Injectable Suspension - Lumbar Radiculopathy, Sciatica | Phase 4 | Not yet recruiting | University of Miami | 150 | 2026-09-15 | 2026-08-12 |
| Isatuximab, Iberdomide, Bortezomib, Dexamethasone in Transplant Ineligible/Deferred Newly Diagnosed Myeloma Isatuximab, Iberdomide, Bortezomib - Newly Diagnosed Multiple Myeloma | Phase 1 / Phase 2 | Not yet recruiting | Dana-Farber Cancer Institute | 88 | 2026-09-03 | 2026-09-03 |
| Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma Arm A: Belantamab Mafodotin, Arm B: Daratumumab Hyaluronidase, Bortezomib - Multiple Myeloma | Phase 3 | Recruiting | PrECOG, LLC. | 500 | 2026-09-01 | 2026-08-17 |
| Time to First Rescue Antiemetic With Ondansetron Plus Metoclopramide Versus Dexamethasone Plus Metoclopramide for PONV Prophylaxis in Laparoscopic Cholecystectomy ondansetron 4 mg, Dexamethasone (intravenous), Metoclopramide 10mg - Postoperative Nausea and Vomiting | Phase 4 | Recruiting | Faisalabad Medical University | 264 | 2026-09-01 | 2026-09-04 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype Dexamethasone, Bortezomib, LENALIDOMIDE - Multiple Myeloma, Triple Negative Breast Cancer | Phase 1 | Recruiting | Andrew Hantel, MD | 90 | 2026-07-30 | 2026-08-17 |
| Post-Operative Steroids After Sleep Surgery 8mg dexamethasone - Obstructive Sleep Apnea | Phase 2 | Withdrawn | Medical University of South Carolina | 2026-07-01 | 2026-10-06 | |
| A Study of Linvo-VR vs DVRd in Transplant-Eligible Adult Participants With Newly Diagnosed Multiple Myeloma (NDMM) Linvoseltamab, Bortezomib, Lenalidomide - Multiple Myeloma (MM) | Phase 2 / Phase 3 | Withdrawn | Regeneron Pharmaceuticals | 2026-06-05 | 2026-06-18 | |
| Isatuximab-VRd in Transplant-Ineligible Newly Diagnosed Multiple Myeloma Patients Isatuximab, Bortezomib, Lenalidomide - Multiple Myeloma | Recruiting | Shanghai Zhongshan Hospital | 333 | 2026-06-01 | 2026-06-23 |
Showing 20 of 807. Sign in to see all of them.
Multiple Myeloma (239) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (69) · Recurrence (38) · Macular Edema (37) · Burkitt Lymphoma (35) · Leukemia (32) · Lymphoma (30) · Nausea (27) · Vomiting (25) · Neoplasms, Plasma Cell (22) · Pain, Postoperative (22) · Cataract (20) · Lymphoma, Non-Hodgkin (19) · Immunoglobulin Light-chain Amyloidosis (18) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (18)
M.D. Anderson Cancer Center (80) · National Cancer Institute (NCI) (50) · Mayo Clinic (34) · Children's Oncology Group (24) · Allergan (23) · Emory University (20) · Dana-Farber Cancer Institute (15) · H. Lee Moffitt Cancer Center and Research Institute (12) · SWOG Cancer Research Network (12) · St. Jude Children's Research Hospital (12) · Bristol-Myers Squibb (9) · Merck Sharp & Dohme LLC (9) · Barbara Ann Karmanos Cancer Institute (8) · City of Hope Medical Center (8) · University of Arkansas (8)
United States (603) · Canada (86) · Australia (50) · Puerto Rico (29) · France (28) · China (27) · Spain (25) · Germany (22) · Italy (21) · Israel (19) · Switzerland (19) · United Kingdom (19) · Brazil (18) · Egypt (18) · New Zealand (18)
Elias Jabbour (7) · Shaji Kumar (6) · Shaji Kumar, M.D. (6) · Rachid Baz, M.D. (4) · Alfred Chung, MD (3) · Andrzej Jakubowiak (3) · Binod Dhakal, MD (3) · Brian GM Durie, MD (3) · Dennis Vargo, MD (3) · Farhad Ravandi-Kashani (3) · James R Berenson, MD (3)
PMID 41671463, PMID 33357481, PMID 35622074, PMID 37890117, PMID 39121442, PMID 22689675, PMID 29567784, PMID 33206392, PMID 17413463, PMID 21519308, PMID 25123271, PMID 25774458, PMID 26181891, PMID 26272769, PMID 26519345, PMID 26581718, PMID 26590194, PMID 29284596, PMID 30293228, PMID 31654188, PMID 33242441, PMID 35132679, PMID 35549810, PMID 36603187, PMID 37505794, PMID 38446568, PMID 38652812, PMID 38826786, PMID 39321347, PMID 40226119, PMID 40315406, PMID 40501401, PMID 40634898, PMID 40688490, PMID 42085640, PMID 10078396, PMID 10475299, PMID 10485781, PMID 10499612, PMID 10624646, PMID 10700684, PMID 10730546, PMID 10895746, PMID 10910848, PMID 11001674, PMID 11351356, PMID 11375828, PMID 11426549, PMID 11445789, PMID 11454483
U10CA098543 (19), U10CA180886 (16), U10CA180820 (12), P30CA015083 (11), P30CA138292 (11), U10CA180888 (11), U10CA021115 (9), U10CA032102 (8), P30CA022453 (7), P30CA016672 (6), P30CA033572 (5), 2025 (3), P30CA014089 (3), P30CA069533 (3), 2016 (2)